ANN ARBOR, MI / January 27, 2022 / Zomedica Corp. (NYSE American:ZOM) ("Zomedica" or the "Company"), a veterinary health company offering diagnostic and therapeutic products for companion animals, today provided an update on its marketing activities during the first...
Zomedica CEO Provides Update to Shareholders
ANN ARBOR, MI / January 10, 2022 / Zomedica Corp. (NYSE American:ZOM) ("Zomedica" or the "Company"), a veterinary health company offering diagnostic and therapeutic products for companion animals, today issued the following letter from Larry Heaton, Chief Executive...
Zomedica to Present at H.C. Wainwright BioConnect 2022 Conference
ANN ARBOR, MI / December 15, 2021 / Zomedica Corp. (NYSE American:ZOM), a veterinary health company offering point-of-care diagnostics and therapeutic products for companion animals, announced today that Larry Heaton, Chief Executive Officer, will present a company...
Zomedica Announces Third Quarter 2021 Financial Results
ANN ARBOR, MI / November 12, 2021 / Zomedica Corp. (NYSE American:ZOM) ("Zomedica" or "Company"), a veterinary health company creating point-of-care diagnostics products for dogs and cats, today reported consolidated financial results for the three and nine months...
Zomedica Appoints Larry Heaton as President and Announces CEO Succession Plan
ANN ARBOR, Mich., Oct. 04, 2021 -- Zomedica Corp. (NYSE American: ZOM) ("Zomedica" or the "Company"), a veterinary health company creating point-of-care diagnostic and therapeutic products for companion animals, today announced that Larry Heaton has been appointed...
Zomedica Acquires PulseVet
ANN ARBOR, Mich., Oct. 01, 2021 -- Zomedica Corp. (NYSE American: ZOM) ("Zomedica" or the "Company"), a veterinary health company creating point-of-care diagnostic and therapeutic products for companion animals, today announced that it had acquired the Pulse...
Sean Whelan Appointed to Board of Directors
ANN ARBOR, Mich., Sept. 13, 2021 -- Zomedica Corp. (NYSE American: ZOM) ("Zomedica" or the "Company"), a veterinary health company creating point-of-care diagnostics products for dogs and cats, announced that Sean Whelan has been appointed to its Board of Directors to...
Zomedica Announces Second Quarter 2021 Financial Results
TRUFORMA® Instrument Placement Program Implemented to Incentivize Future Assay SalesANN ARBOR, Mich., Aug. 11, 2021 -- Zomedica Corp. (NYSE American: ZOM) ("Zomedica" or the "Company"), a veterinary health company creating point-of-care diagnostics products for...
Zomedica Announces 2021 Annual Meeting Results
ANN ARBOR, Mich., July 30, 2021 -- Zomedica Corp. (NYSE American: ZOM) ("Zomedica" or the "Company"), a veterinary health company creating point-of-care diagnostics products for companion animals, today announced the voting results of its 2021 Annual Virtual-Only...
Zomedica Provides Corporate Update
FOCUSED ON TRUFORMA® INSTRUMENT PLACEMENTS AND BUILDING DIRECT SALES ORGANIZATION ANN ARBOR, Mich., July 06, 2021 -- Zomedica Corp. (NYSE American: ZOM) ("Zomedica" or the "Company"), a veterinary health company creating point-of-care diagnostics products for...